Rashid Alvi currently serves as Chief Strategy Officer and V.P. of Operations at NovoPath, Inc. Mr. Alvi formerly served as Managing Director of the Harvard Capital Group. Prior to his post at the Harvard Capital group, Mr. Alvi was the Deputy Director of the Islamic Legal Studies Program (ILSP) at Harvard Law School. Prior to Harvard Capital Group and ILSP, at the law firm of Davis Polk & Wardwell, Mr. Alvi specialized in mergers and acquisitions. He then moved to Wall Street, working at Lehman Brothers and Goldman Sachs. He subsequently joined Acro Healthcare, LLC, a privately held start-up company in the specialty pharmaceuticals industry, in an executive capacity. After helping the company grow, Mr. Alvi advised on its sale to Lincare, Inc., a public company. Following the sale of Acro, Mr. Alvi worked as a principal at a boutique business advisory firm, where he continues to consult from time to time. Mr. Alvi holds a J.D. from Columbia Law School, an M.A. from the University of Southern California, and a B.A. from Binghamton University.